CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Dailies Total1® contact lenses for astigmatism (T30fA)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05938010
NCT05938010N/ACompleted
CompareCT.gov

Subjective Wearing Experience of the Total30 for Astigmatism Lens Among Satisfied Biofinity Toric Lens Wearers

Scripps Poway Eyecare and Optometry·observational·Posted Jul 10, 2023·Updated Nov 14, 2024

In Brief

An observational study evaluating Dailies Total1® contact lenses for astigmatism (T30fA) for Astigmatism. Completed, enrolled 42 participants across 1 site.

Detailed Summary

To subjectively evaluate wearing experience in the T30fA lens among subjects who were already satisfied with their Biofinity Toric lenses.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAstigmatism
CountriesUnited States
CollaboratorsSengi

Timeline

N/ACompletedFinished
202420252026
First PostedJul 10, 2023
Enrollment StartJul 25, 2023
Primary CompletionSep 26, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.0 years ago

Interventions

Dailies Total1® contact lenses for astigmatism (T30fA)device

Dailies Total1® contact lenses for astigmatism (T30fA)